Nirman Agri Genetics Past Earnings Performance
Past criteria checks 4/6
Nirman Agri Genetics has been growing earnings at an average annual rate of 75.9%, while the Biotechs industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 66.3% per year. Nirman Agri Genetics's return on equity is 27.9%, and it has net margins of 16.4%.
Key information
75.9%
Earnings growth rate
55.6%
EPS growth rate
Biotechs Industry Growth | 5.1% |
Revenue growth rate | 66.3% |
Return on equity | 27.9% |
Net Margin | 16.4% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Nirman Agri Genetics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 633 | 104 | 15 | 0 |
31 Mar 23 | 286 | 40 | 10 | 0 |
31 Mar 22 | 135 | 26 | 5 | 0 |
31 Mar 21 | 66 | 1 | 3 | 0 |
Quality Earnings: NIRMAN has high quality earnings.
Growing Profit Margin: NIRMAN's current net profit margins (16.4%) are higher than last year (14%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if NIRMAN's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare NIRMAN's past year earnings growth to its 5-year average.
Earnings vs Industry: NIRMAN earnings growth over the past year (159.8%) exceeded the Biotechs industry -2.3%.
Return on Equity
High ROE: NIRMAN's Return on Equity (27.9%) is considered high.